Susquehanna International Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.2M | Sell |
92,900
-21,500
| -19% | -$4.18M | ﹤0.01% | 2348 |
|
|
2025
Q4 | $19.9M | Sell |
114,400
-157,000
| -58% | -$28.6M | ﹤0.01% | 2215 |
|
|
2025
Q3 | $51.7M | Buy |
271,400
+47,900
| +21% | +$8.5M | 0.01% | 1318 |
|
|
2025
Q2 | $40.1M | Buy |
223,500
+67,800
| +44% | +$11.8M | 0.01% | 1327 |
|
|
2025
Q1 | $26.3M | Buy |
155,700
+142,600
| +1,089% | +$23.4M | ﹤0.01% | 1495 |
|
|
2024
Q4 | $1.98M | Sell |
13,100
-24,600
| -65% | -$3.83M | ﹤0.01% | 5345 |
|
|
2024
Q3 | $5.85M | Sell |
37,700
-27,800
| -42% | -$4.15M | ﹤0.01% | 3338 |
|
|
2024
Q2 | $8.97M | Sell |
65,500
-34,300
| -34% | -$4.7M | ﹤0.01% | 2629 |
|
|
2024
Q1 | $13.3M | Sell |
99,800
-44,300
| -31% | -$5.75M | ﹤0.01% | 2243 |
|
|
2023
Q4 | $19.9M | Buy |
144,100
+83,300
| +137% | +$11M | ﹤0.01% | 1825 |
|
|
2023
Q3 | $7.41M | Buy |
60,800
+16,100
| +36% | +$2.15M | ﹤0.01% | 2944 |
|
|
2023
Q2 | $6.28M | Sell |
44,700
-13,500
| -23% | -$1.86M | ﹤0.01% | 3162 |
|
|
2023
Q1 | $8.23M | Buy |
58,200
+21,900
| +60% | +$3.13M | ﹤0.01% | 2729 |
|
|
2022
Q4 | $5.68M | Buy |
36,300
+10,800
| +42% | +$1.55M | ﹤0.01% | 3043 |
|
|
2022
Q3 | $3.13M | Buy |
25,500
+6,300
| +33% | +$830K | ﹤0.01% | 4000 |
|
|
2022
Q2 | $2.55M | Sell |
19,200
-7,800
| -29% | -$1.06M | ﹤0.01% | 4387 |
|
|
2022
Q1 | $3.69M | Buy |
27,000
+3,900
| +17% | +$544K | ﹤0.01% | 4231 |
|
|
2021
Q4 | $4M | Sell |
23,100
-205,900
| -90% | -$31.3M | ﹤0.01% | 4126 |
|
|
2021
Q3 | $33.3M | Buy |
229,000
+24,500
| +12% | +$3.58M | ﹤0.01% | 1492 |
|
|
2021
Q2 | $27M | Buy |
204,500
+125,100
| +158% | +$16.4M | ﹤0.01% | 1712 |
|
|
2021
Q1 | $10.2M | Buy |
79,400
+16,400
| +26% | +$2.02M | ﹤0.01% | 2739 |
|
|
2020
Q4 | $7.51M | Sell |
63,000
-89,100
| -59% | -$10.9M | ﹤0.01% | 2851 |
|
|
2020
Q3 | $17.4M | Buy |
152,100
+17,500
| +13% | +$2.07M | ﹤0.01% | 1608 |
|
|
2020
Q2 | $15.3M | Sell |
134,600
-51,800
| -28% | -$5.49M | ﹤0.01% | 1680 |
|
|
2020
Q1 | $15M | Buy |
186,400
+142,100
| +321% | +$14.7M | ﹤0.01% | 1392 |
|
|
2019
Q4 | $4.73M | Sell |
44,300
-44,800
| -50% | -$4.67M | ﹤0.01% | 3041 |
|
|
2019
Q3 | $9.54M | Sell |
89,100
-2,900
| -3% | -$298K | ﹤0.01% | 2031 |
|
|
2019
Q2 | $9.37M | Sell |
92,000
-55,300
| -38% | -$5.31M | ﹤0.01% | 1944 |
|
|
2019
Q1 | $13.2M | Sell |
147,300
-29,600
| -17% | -$2.56M | 0.01% | 1509 |
|
|
2018
Q4 | $14.7M | Buy |
176,900
+41,100
| +30% | +$3.85M | 0.01% | 1287 |
|
|
2018
Q3 | $14.7M | Sell |
135,800
-3,000
| -2% | -$329K | ﹤0.01% | 1587 |
|
|
2018
Q2 | $15.3M | Sell |
138,800
-30,800
| -18% | -$3.21M | 0.01% | 1530 |
|
|
2018
Q1 | $17M | Buy |
169,600
+43,100
| +34% | +$4.41M | 0.01% | 1335 |
|
|
2017
Q4 | $12.5M | Buy |
126,500
+20,900
| +20% | +$1.98M | ﹤0.01% | 1647 |
|
|
2017
Q3 | $9.89M | Buy |
105,600
+45,800
| +77% | +$4.86M | ﹤0.01% | 1781 |
|
|
2017
Q2 | $6.65M | Buy |
59,800
+14,900
| +33% | +$1.58M | ﹤0.01% | 2075 |
|
|
2017
Q1 | $4.41M | Sell |
44,900
-4,800
| -10% | -$458K | ﹤0.01% | 2502 |
|
|
2016
Q4 | $4.57M | Sell |
49,700
-6,900
| -12% | -$595K | ﹤0.01% | 2565 |
|
|
2016
Q3 | $4.79M | Sell |
56,600
-16,500
| -23% | -$1.39M | ﹤0.01% | 2292 |
|
|
2016
Q2 | $5.95M | Sell |
73,100
-77,500
| -51% | -$5.9M | ﹤0.01% | 1990 |
|
|
2016
Q1 | $10.8M | Buy |
150,600
+61,700
| +69% | +$4.14M | 0.01% | 1479 |
|
|
2015
Q4 | $6.32M | Sell |
88,900
-79,700
| -47% | -$5.36M | ﹤0.01% | 2232 |
|
|
2015
Q3 | $10.4M | Sell |
168,600
-35,200
| -17% | -$2.46M | ﹤0.01% | 1787 |
|
|
2015
Q2 | $14.8M | Sell |
203,800
-429,500
| -68% | -$31.7M | 0.01% | 1598 |
|
|
2015
Q1 | $48.7M | Buy |
633,300
+483,700
| +323% | +$34.6M | 0.02% | 649 |
|
|
2014
Q4 | $10M | Sell |
149,600
-70,500
| -32% | -$4.45M | ﹤0.01% | 2027 |
|
|
2014
Q3 | $13.4M | Sell |
220,100
-53,800
| -20% | -$3.32M | 0.01% | 1794 |
|
|
2014
Q2 | $16.1M | Sell |
273,900
-85,200
| -24% | -$4.99M | 0.01% | 1593 |
|
|
2014
Q1 | $20.8M | Buy |
359,100
+22,400
| +7% | +$1.2M | 0.01% | 1245 |
|
|
2013
Q4 | $18M | Buy |
336,700
+292,800
| +667% | +$17.4M | 0.01% | 1450 |
|
|
2013
Q3 | $2.71M | Sell |
43,900
-31,800
| -42% | -$1.9M | ﹤0.01% | 3630 |
|
|
2013
Q2 | $4.59M | Buy |
+75,700
| New | +$4.51M | ﹤0.01% | 2742 |
|
Other funds holding DGX
VCM
VPM
EIG
Susquehanna International Group's DGX Position: Q1 2026 in Review
Susquehanna International Group reduced its Quest Diagnostics (DGX) stake by 40% in Q1 2026, selling an estimated $2.35M and leaving 18,519 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #4865.
Susquehanna International Group first reported a position in DGX in Q2 2013 and has held it in 47 quarters since. The position peaked at $11.9M in Q3 2013. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Susquehanna International Group held 18,519 shares of Quest Diagnostics worth $3.63M as of Q1 2026.
- Susquehanna International Group sold 12,109 Quest Diagnostics shares in Q1 2026, an estimated $2.35M.
- Quest Diagnostics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4865 holding.
- Susquehanna International Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 47 quarters since.
- Susquehanna International Group's Quest Diagnostics position peaked at $11.9M in Q3 2013.
- 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.